Monday, October 26, 2026 · Daily editionET --:--:--

Status not kept up to date

Clinical Study of the Effects of a SWalker II and VR for Hip Fracture Rehabilitation in the Elderly

NCT06025981 · Werium Assistive Solutions · Updated 6 Sept 2023

What is being tested
Preliminary Phase; Phase I - Early gait rehabilitation; Phase II - Maintenance gait function ( with VR)
For
Hip Fractures; Gait Disorders in Old Age
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages Not stated. About 100 people. The full rules are on the registry page.
Where
Spain (2 sites)
When
Starts or started 10 Jan 2023, ends 30 Dec 2023. Registered 6 Sept 2023.
Results
None posted yet.

In the researchers' words

This project is structured in two distinct phases. The first phase deals with the recovery of the hip fracture in the acute phase up to ambulation, and the second is understood as the continuation of functional improvement of gait. In the first phase, the aim is to evaluate the effects of the use of the robotic device (SWalker) on the physical improvement of the patient. While in the second phase, the objective is to evaluate the effects of virtual reality technology combined with the use of the SWalker.Therefore, the following specific objectives are identified: * Phase I: To analyze the effects of SWalker application in patients with acute hip fracture on clinical parameters of rehabilitation. * Phase II: To study the effects of the application of the SWalker combined with immersive technology in people with impaired gait function after hip fracture.
ClinicalTrials.gov, NCT06025981

Sites

  • Werium Assistive SolutionsArganda, Madrid, Spain
  • Albertia Servicios SociosanitariosMadrid, Spain